Vaxcyte, Inc. SEC filings PCVX
Vaxcyte, Inc. has 767 filings in SEC EDGAR's recent list, going back to Jul 24, 2015. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Oct 9, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 3, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 15, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 23, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Other events
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Other events
|
Feb 2, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 19, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Material agreement
|
Sep 30, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Officer or director change
|
May 1, 2025 | May 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 21, 2024 | Nov 15, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Other events
|
Sep 6, 2024 | Sep 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 3, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Other events
|
Jan 31, 2024 | Jan 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 28, 2023 | Nov 27, 2023 |
| 8-K |
Current report
Material agreement
|
Nov 27, 2023 | Nov 21, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 16, 2023 | Oct 13, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 4, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Material agreement
|
Sep 7, 2023 | Sep 1, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Other events
|
Apr 20, 2023 | Apr 18, 2023 |
| 8-K |
Current report
Other events
|
Apr 17, 2023 | Apr 17, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 6, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Other events
|
Feb 27, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Material agreement
|
Dec 20, 2022 | Dec 19, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 12, 2022 | Dec 6, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Other events
|
Oct 27, 2022 | Oct 25, 2022 |
| 8-K |
Current report
Other events
|
Oct 24, 2022 | Oct 24, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2022 | Jun 1, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Material agreement
|
Apr 18, 2022 | Apr 12, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Other events
|
Jan 13, 2022 | Jan 12, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 28, 2021 | Oct 26, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2021 | Sep 16, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2021 | Mar 29, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2021 | Mar 24, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 25, 2021 | Jan 21, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 22, 2020 | Dec 16, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 12, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2020 | Aug 12, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jun 16, 2020 | Jun 16, 2020 |
Showing 69 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PCVX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Carlos, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1649094
- Former names
- SutroVax, Inc. (until Apr 3, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.